<DOC>
	<DOCNO>NCT00272571</DOCNO>
	<brief_summary>The objective study test hypothesis external counter pulsation therapy ( ECPT ) provide clinical benefit improve number function endothelial progenitor cell ( EPCs ) peripheral blood patient angina pectoris .</brief_summary>
	<brief_title>The Effects External Counter Pulsation Therapy Circulating Endothelial Progenitor Cells</brief_title>
	<detailed_description>ECPT non-invasive approach increase blood flow heart patient myocardial ischemia . ECPT produce beneficial effect coronary artery disease ( CAD ) patient . However , exact mechanism ECPT action define yet . Evidence accumulate bone marrow-derived cell angiogenic capability , term EPCs , circulate blood adult . EPCs possess ability home site ischemia contribute neoangiogenesis . We prospectively study CAD patient [ Canadian Cardiovascular Society ( CCS ) angina class II-IV ] , ECPT , compare age- sex-matched control . Peripheral blood CD34+ cell , EPCs ( CD34/VEGFR2+ cell ) , EPC colony form unit ( CFUs ) brachial artery endothelial function assess prior ECPT . Percent improvement endothelium-dependent brachial artery flow-mediated dilatation ( % FMD ) assess use high-resolution ultrasound .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>coronary artery disease CCS angina class IIIV aortic regurgitation acute myocardial infarction &lt; 3 month systemic hypertension &gt; 180/110 mm atrial fibrillation deep vein thrombosis phlebitis hemorrhagic diathesis pregnancy abdominal aortic aneurism metastatic tumor</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>ECPT , endothelial progenitor cell</keyword>
</DOC>